Meridian Bioscience reported $19.72M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US $ 2.74B 14M
Accelerate Diagnostics AXDX:US 10.81M 2.1M
Atrion ATRI:US 6.92M 292K
Becton, Dickinson and BDX:US $ 1.33B 95M
Bio Rad Laboratories BIO:US $ 211.7M 8.62M
Cerulean Pharma CERU:US $ 2.24M 413.69K
Cerus CERS:US $ 20.36M 599K
Genmark Diagnostics GNMK:US $ 12.4M 2.06M
Luminex LMNX:US $ 36.18M 1.04M
Meridian Bioscience VIVO:US $ 19.72M 1.55M
Myriad Genetics MYGN:US $ 180.2M 45.4M
Neogen NEOG:US $ 33.94M 579K
Orasure Technologies OSUR:US $ 26.38M 4.97M
Oxford Immunotec Global OXFD:US 11.97M 934K
Quidel QDEL:US $ 67.89M 8.65M
Sientra SIEN:US 19.92M 1.9M
Staar Surgical STAA:US $ 29.19M 1.1M
Thermo Fisher Scientific TMO:US $ 1.73B 214M
Trinity Biotech TRIB:US 6.59M 192K